Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
As of September 2023 it is on the FDA's Category 2 list of bulk drug substances that may not be compounded due to significant safety risks, and the agency has scheduled a Pharmacy Compounding Advisory Committee (PCAC) review for July 2026 covering proposed uses in opioid withdrawal, chronic insomnia, and narcolepsy
Long-Term Safety and Toxicity Animal studies have not consistently shown major toxicity signals, which is one reason interest in BPC 157 has continued
B., Fakurazi, S
Pediatric Use
The anti-aging properties of GHK-Cu reflect its fundamental role in maintaining tissue homeostasis and counteracting age-related decline in regenerative capacity
US$ 24.29
US$ 28.01
US$ 27.70
US$ 26.80
